Viewing Study NCT04143646



Ignite Creation Date: 2024-05-06 @ 1:51 PM
Last Modification Date: 2024-10-26 @ 1:21 PM
Study NCT ID: NCT04143646
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-03-03
First Post: 2019-10-23

Brief Title: New Technologies for Intensive Prevention Programs - NET-IPP
Sponsor: Herzzentrum Bremen
Organization: Herzzentrum Bremen

Study Overview

Official Title: New Technologies for Intensive Prevention Programs - NET-IPP
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NET-IPP
Brief Summary: In a randomized trial patients hospitalized for myocardial infarction are prospectively enrolled and assigned to either a web-based intensive prevention program or usual care 1 1 randomization The web-based program includes telemetric transmission of data on cardiocascular risk factors physical activity blood pressure body weight by patients to the study center e-learning modules by the study center and repetitive electronic contacts by e-mails and apps between a prevention assistant and the patient

In addition genetic risk on cardiovascular events will be assessed in all patients of the intervention group by a polygenetic risk score PRS Patients of the intervention group are randomly assigned to disclosure of genetic risk vs no disclosure The study hypothesis is that disclosure of genetic risk improves cardiovascular risk factor control by increased patient motivation
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None